30 results
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
, Canada, the European Union, the United Kingdom and Israel. The AnnJi License Agreement also contains customary representations and warranties
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
indications (other than androgenetic alopecia and Alzheimer’s disease) in the United States, Canada, the European Union, the United Kingdom and Israel
8-K
EX-10.2
b4b24muqbcu0h4l q4x
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-1.1
vjhrfrnibmi4h0rqe
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
7bx7 qgoy
11 Oct 22
Prospectus supplement with pricing info
8:27am